China · Delayed Price · Currency is CNY Berry Genomics Co.,Ltd Company Description
Berry Genomics Co.,Ltd, a genomics and life science company, develops and commercializes of genetic test technologies in clinical applications in China.
The company offers non-invasive DNA prenatal testing service, genetic disease testing, tumor genetic testing, NextSeq CN500 gene sequencer, and laboratory solutions.
It also provides technology services, such as human genome sequencing, transcriptional regulation, single cell/spatial sequencing, animal and plant genome resequencing, genome denovo sequencing, and microbial sequencing, as well as big data services.
The company serves various organizations and facilities, including hospitals, research institutions, universities, and enterprises throughout Mainland China, Hong Kong, Macao, Taiwan, Southeast Asia, the Middle East, and Australia.
The company was founded in 1997 and is headquartered in Beijing, China.
| Country | China |
| Founded | 1997 |
| Industry | Diagnostics & Research |
| Sector | Healthcare |
| Employees | 1,402 |
| CEO | Yang Gao |
Contact Details
Address: Building 5 Beijing China | |
| Phone | 86 10 5325 9188 |
| Website | berrygenomics.com |
Stock Details
| Ticker Symbol | 000710 |
| Exchange | Shenzhen Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE000000PN7 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Dr. Yang Gao | GM and Chairman |
| Dong Wang | Chief Financial Officer, Deputy GM and Director |
| Dr. Daixing Zhou | Co-Founder and Chief Scientist |
| Li Gao | Accounting Supervisor |